TM4SF1: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: TM4SF1

NCBI ID: G4071

TM4SF1

TM4SF1: A Potential Drug Target for Cancer and Neurodegenerative Diseases

TM4SF1, also known as membrane component 4SF1 or surface marker 1, is a protein located on chromosome 3 that is expressed in various tissues and cell types in the body. It is a transmembrane protein that is involved in various cellular processes, including cell signaling, cell adhesion, and intracellular routing of various signaling molecules.

TM4SF1 has been identified as a potential drug target due to its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has also been linked to various cellular processes that are important for human health, including the development and progression of cancer, the regulation of cell growth and division, and the maintenance of tissue homeostasis.

One of the key functions of TM4SF1 is its role in cell signaling. TM4SF1 is involved in the formation of the cytoskeleton and is a component of the protein complex known as the adaptor protein complex, which is involved in the regulation of actin dynamics and cytoskeletal organization. This protein complex plays a role in the regulation of various cellular processes, including cell migration, the assembly and disassembly of actin filaments, and the regulation of cytoskeletal dynamics.

In addition to its role in cell signaling, TM4SF1 is also involved in the regulation of cell adhesion. TM4SF1 is a component of the cadherin complex, which is involved in the regulation of cell-cell adhesion and the development of tissues and organs. This protein complex plays a role in the regulation of various cellular processes, including cell adhesion, the formation of tissues and organs, and the regulation of cell proliferation.

Another function of TM4SF1 is its role in intracellular routing of signaling molecules. TM4SF1 is involved in the regulation of the distribution and localization of various signaling molecules, including tyrosine kinases, heat shock proteins, and chemokines. This protein is also involved in the regulation of the trafficking of these signaling molecules to their final destinations and in the regulation of their stability and degradation.

TM4SF1 has also been linked to the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has been observed in a variety of cancer types, including breast, ovarian, and prostate cancer. In addition, TM4SF1 has been linked to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Furthermore, TM4SF1 has also been shown to play a role in the regulation of various physiological processes that are important for human health, including the development and progression of cancer, the regulation of cell growth and division, and the maintenance of tissue homeostasis. Its expression has been observed in various tissues and cells, including blood vessels, tissues, and organs, and its function in these processes is still being studied.

In conclusion, TM4SF1 is a transmembrane protein that is involved in various cellular processes, including cell signaling, cell adhesion, and intracellular routing of signaling molecules. Its expression has been linked to the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, TM4SF1 is a potential drug target for the development of new therapies for these diseases. Further research is needed to fully understand the function of TM4SF1 and its potential as a drug target.

Protein Name: Transmembrane 4 L Six Family Member 1

The "TM4SF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TM4SF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets